Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves 1st self-administered flu vaccine
FDA approves self-administered flu vaccine nasal spray
The FDA has approved AstraZeneca's FluMist nasal spray to be used outside of a health care setting. Outside a Trump rally in Pennsylvania, young people in MAGA hats say they’re scared for their future
FDA approves AstraZeneca FluMist flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration.
FDA just greenlighted an at-home flu vaccine. What the approval of a self-administered spray means for you.
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
4d
FDA approves ‘FluMist,' says no healthcare provider needed
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
1d
Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
Daily
3d
AstraZeneca FluMist gets USFDA nod for self-administered influenza vaccine
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
Islander News
3d
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination will boost uptake
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Live attenuated influenza vaccine
Food and Drug Administration
Feedback